# A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: Amgen · Condition: Non-Small Cell Lung Cancer (NSCLC)

- Company: Amgen
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05920356

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.